Suscribirse

Comparison of three echo-guidance techniques in percutaneous patent foramen ovale closure for stroke prevention: Conventional transoesophageal, microprobe transoesophageal and intracardiac echocardiography - 28/10/23

Doi : 10.1016/j.acvd.2023.08.006 
Iphigénie Reibel, Marie Hauguel-Moreau, Paul Guedeney, Georges Hage, Nadjib Hammoudi, Guillaume Duthoit, Michel Zeitouni, Benoit Lattuca, Mathieu Kernéis, Jean-Philippe Collet, Johanne Silvain, Gilles Montalescot

for the ACTION Study Group

 Institut de Cardiologie, ACTION Study Group, hôpital Pitié-Salpêtrière, AP–HP, Sorbonne université, Inserm UMRS_1166, 47–83, boulevard de l’Hôpital, 75013 Paris, France 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Graphical abstract




El texto completo de este artículo está disponible en PDF.

Highlights

The number of PFO closures has increased since 2018.
There is therefore a need to simplify the closure procedure.
ICE and microTEE are mini-invasive alternatives to guide PFO closure.
These techniques avoid the need for general anaesthesia.
Their safety and efficacy are similar to conventional TEE under general anaesthesia.
Fluoroscopic exposure time and X-ray dose were lower in the microTEE group.
This finding reflects the decreased procedure time with microTEE.
The main microTEE drawback is patient discomfort, especially during probe insertion.

El texto completo de este artículo está disponible en PDF.

Abstract

Background

Recent randomized trials have demonstrated a consistent reduction in recurrent stroke after percutaneous transcatheter patent foramen ovale closure versus medical therapy in patients with recent cryptogenic stroke.

Aim

To compare the safety and efficacy of intracardiac echocardiography-guided and microprobe transoesophageal echocardiography-guided patent foramen ovale closure under local anaesthesia with transoesophageal echocardiography-guided patent foramen ovale closure under general anaesthesia.

Methods

This prospective observational single-centre study included 194 consecutive patients scheduled for patent foramen ovale closure for secondary prevention of stroke from February 2018 to December 2019. Patients were asked to choose between an intracardiac echocardiography-guided, microprobe transoesophageal echocardiography-guided or transoesophageal echocardiography-guided procedure. The primary endpoint was the rate of successful closure at 6 months, defined as correct positioning of the device without severe shunt on 6-month contrast echocardiography.

Results

Successful closure was high and did not differ between groups: 97.8% (95% confidence interval 88.5–99.9%) in the intracardiac echocardiography-guided group versus 96.9% (95% confidence interval 83.8–99.9%) in the microprobe transoesophageal echocardiography-guided group and 99.1% (95% confidence interval 95.3–99.9%) in the transoesophageal echocardiography-guided group (P=0.63). Adverse events related to patent foramen ovale closure were low and did not differ between groups.

Conclusion

Our preliminary real-world experience suggests good efficacy and safety with intracardiac echocardiography and microprobe transoesophageal echocardiography guidance compared with conventional transoesophageal echocardiography guidance for percutaneous transcatheter patent foramen ovale closure in recurrent stroke prevention.

El texto completo de este artículo está disponible en PDF.

Keywords : Patent foramen ovale, Intracardiac echography, Multiplane transoesophageal echocardiography, Microprobe transoesophageal echocardiography, Cryptogenic stroke, Structural heart disease

Abbreviations : 3D, CI, ICE, ICM, PFO, MicroTEE, TEE


Esquema


© 2023  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 116 - N° 11

P. 523-528 - novembre 2023 Regresar al número
Artículo precedente Artículo precedente
  • Mitral annular disjunction and Pickelhaube sign in children with mitral valve prolapse: A prospective cohort study
  • Guy Vaksmann, Ivan Bouzguenda, Marie-Paule Guillaume, Pauline Gras, Valentina Silvestri, Adélaïde Richard
| Artículo siguiente Artículo siguiente
  • Functional imaging after the “ISCHEMIA” trial
  • Suzanne Duhamel, Théo Pezel, Jérôme Garot

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.